General information to be included in applications for the recognition of disease-free status:
Date of application.
Name of the country.
Name of disease.
Territorial scope as regards the recognition of disease-free status.
Statement confirming that the relevant general criteria in accordance with point (a) of Article 66 of Delegated Regulation (EU) 2020/689 for Member States or zones, or with point (a) of Article 73(1) of that Delegated Regulation for aquatic compartments, are complied with.
Information to be included in applications for the recognition of disease-free status based on the absence of listed species:
Documentation in accordance with Articles 67(2) or 74(2) of Delegated Regulation (EU) 2020/689.
Information to be included in applications for the recognition of disease-free status based on the disease agent’s incapacity to survive:
Documentation in accordance with Articles 68(2) or 75(2) of Delegated Regulation (EU) 2020/689.
Information to be included in applications for the recognition of disease-free status based on the incapacity to survive of listed vectors for listed diseases of terrestrial animals:
Documentation in accordance with Article 69(2) of Delegated Regulation (EU) 2020/689.
Information to be included by the competent authority in applications for the recognition of a disease-free status for Member State, or a zone or compartment thereof, if more than one zone or compartment are included in the territorial scope of the application, where the disease has been reported in the previous 25 years, and it has been eradicated from the territory concerned:
Disease-free status from infection with Brucella abortus, B. melitensis and B. suis as regards kept bovine animals:
the information referred to in point 1 of Section 6 of Annex VI;
the criteria requested by the competent authority to grant, maintain, suspend and restore, withdraw and regain disease-free status from infection with Brucella abortus, B. melitensis and B. suis with or without vaccination at establishment level;
any other information and data necessary to demonstrate compliance with the requirements of Article 72, point (a), of Delegated Regulation (EU) 2020/689.
Disease-free status from infection with Brucella abortus, B. melitensis and B. suis as regards kept ovine and caprine animals:
the information referred to in point 2 of Section 6 of Annex VI;
the criteria requested by the competent authority to grant, maintain, suspend and restore, withdraw and regain disease-free status from infection with Brucella abortus, B. melitensis and B. Suis with or without vaccination at establishment level;
any other information and data necessary to demonstrate compliance with the requirements of Article 72, point (a), of Delegated Regulation (EU) 2020/689.
Disease-free status from infection with MTBC:
the information referred to in point 3 of Section 6 of Annex VI;
the criteria requested by the competent authority to grant, maintain, suspend and restore, withdraw and regain disease-free status from infection with MTBC at establishment level;
any other information and data necessary to demonstrate compliance with the requirements of Article 72, point (b), of Delegated Regulation (EU) 2020/689.
Disease-free status from EBL:
the information referred to in point 4 of Section 6 of Annex VI;
the criteria requested by the competent authority to grant, maintain, suspend and restore, withdraw and regain disease-free status from EBL at establishment level;
any other information and data necessary to demonstrate compliance with the requirements of Article 72, point (c), of Delegated Regulation (EU) 2020/689.
Disease-free status from IBR/IPV:
the information referred to in point 5 of Section 6 of Annex VI;
the criteria requested by the competent authority to grant, maintain, suspend and restore, withdraw and regain disease-free status from IBR/IPV at establishment level;
any other information and data necessary to demonstrate compliance with the requirements of Article 72, point (d), of Delegated Regulation (EU) 2020/689.
Disease-free status from infection with ADV:
the information referred to in point 6 of Section 6 of Annex VI;
the criteria requested by the competent authority to grant, maintain, suspend and restore, withdraw and regain disease-free status from infection with ADV at establishment level;
any other information and data necessary to demonstrate compliance with the requirements of Article 72, point (e), of Delegated Regulation (EU) 2020/689.
Disease-free status from BVD:
the information referred to in point 7 of Section 6 of Annex VI;
the criteria requested by the competent authority to grant, maintain, suspend and restore, withdraw and regain disease-free status from BVD at establishment level;
any other information and data necessary to demonstrate compliance with the requirements of Article 72, point (f), of Delegated Regulation (EU) 2020/689.
Disease-free status from infection with RABV:
the information referred to in point 8 of Section 6 of Annex VI;
any other information and data necessary to demonstrate compliance with the requirements of Article 72, point (g), of Delegated Regulation (EU) 2020/689.
Disease-free status from category B and C diseases of aquatic animals:
the information referred to in point 10 of Section 6 of Annex VI;
the criteria requested by the competent authority to grant, maintain, suspend and restore, withdraw and regain disease-free status from category B and C diseases of aquatic animals at establishment level;
any other information and data necessary to demonstrate compliance with the requirements of Article 72, points (k) to (q), of Delegated Regulation (EU) 2020/689.
Information on documented evidence on compliance with the requirements set out in points (a) to (f) of Section 1 of Part III of Annex V to Delegated Regulation (EU) 2020/689 shall be included in applications for the recognition of disease-free status for infestation with Varroa spp., where the disease either has never been reported, or it has been eradicated and not reported for at least 25 years, prior to the date of application for the recognition of disease-free status.
Information on documented evidence on compliance the requirements set out in points (a) to (e) of Section 1 of Part IV of Annex V to Delegated Regulation (EU) 2020/689 shall be included in applications for the recognition of disease-free status from infection with Newcastle disease virus infection without vaccination.
Information to be included in applications for the recognition of disease-free status based on eradication programmes, by calendar year:
in the case of eradication programmes for infection with Brucella abortus, B. melitensis and B. suis as regards kept bovine animals by zone, if more than one zone is included in the territorial scope of the programme:
number of establishments keeping bovine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 at 31 December of each year for the last three years;
number of bovine animals kept in the establishments referred to in point (a) at 31 December of each year for the last three years;
number of establishments keeping bovine animals with the status free from infection with Brucella abortus, B. melitensis and B. suis without vaccination including establishments with suspended disease-free status at 31 December of each year for the last three years;
number of bovine animals kept in the establishments referred to in point (c) at 31 December of each year for the last three years;
number of establishments keeping bovine animals tested with a serological test for infection with Brucella abortus, B. melitensis and B. suis each year for the last three years;
number of establishments with suspicion following the testing referred to in point (e) each year for the last three years;
number of abortion cases from kept bovine animals that may have been caused by infection with Brucella abortus, B. melitensis and B. suis investigated each year for the last three years;
date of last confirmed case of infection with Brucella abortus, B. melitensis and B. suis in kept bovine animals;
date of last vaccination against infection with Brucella abortus, B. melitensis and B. suis of kept bovine animals;
in the case of eradication programmes for infection with Brucella abortus, B. melitensis and B. suis as regards kept ovine and caprine animals, by zone, if more than one zone is included in the territorial scope of the programme:
number of establishments keeping ovine or caprine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 at 31 December of each year for the last three years;
number of ovine and caprine animals kept in the establishments referred to in point (a) at 31 December of each year for the last three years;
number of establishments keeping ovine or caprine animals with the status free from infection with Brucella abortus, B. melitensis and B. suis without vaccination including establishments with suspended disease-free status at 31 December of each year for the last three years;
number of ovine and caprine animals kept in the establishments referred to in point (c) at 31 December of each year for the last three years;
number of establishments keeping ovine or caprine animals tested for infection with Brucella abortus, B. melitensis and B. suis each year for the last three years;
number of establishments with suspicion following the testing referred to in point (e) each year for the last three years;
number of abortion cases from ovine or caprine animals that may have been caused by infection with Brucella abortus, B. melitensis and B. suis investigated each year for the last three years;
date of last confirmed case of infection with Brucella abortus, B. melitensis and B. suis in kept ovine or caprine animals;
date of last vaccination against infection with Brucella abortus, B. melitensis and B. suis of kept ovine or caprine animals;
in the case of eradication programmes for infection with MTBC, by zone, if more than one zone is included in the territorial scope of the programme:
number of establishments keeping bovine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 at 31 December of each year for the last three years;
number of bovine animals kept in the establishments referred to in point (a) at 31 December of each year for the last three years;
number of establishments keeping bovine animals with the status free from infection with MTBC including establishments with suspended disease-free status at 31 December of each year for the last three years;
number of bovine animals kept in the establishments referred to in point (c) at 31 December of each year for the last three years;
number of establishments keeping bovine animals tested for MTBC each year for the last three years;
number of establishments with suspicion following the testing referred to in point (e) each year for the last three years;
number of bovine animals slaughtered, presenting suspected lesions of infection with MTBC that have been investigated each year the last three years;
number of establishments confirmed infected with MTBC each year the last three years;
in the case of eradication programmes for EBL, by zone, if more than one zone is included in the territorial scope of the programme:
number of establishments keeping bovine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 at 31 December of each year for the last three years;
number of bovine animals kept in the establishments referred to in point (a) at 31 December of each year for the last three years;
number of establishments keeping bovine animals with the status free from EBL including establishments with suspended disease-free status at 31 December of each year for the last three years;
number of bovine animals kept in the establishments referred to in point (c) at 31 December of each year for the last three years;
number of establishments keeping bovine animals tested for EBL each year for the last three years;
number of establishments with suspicion following the testing referred to in point (e) each year for the last three years;
number of samples from slaughtered bovine animals over 24 months of age with tumors that could be caused by EBL being subjected to laboratory examination to confirm or rule out the presence of EBL each year for the last three years;
number of establishments confirmed infected with EBL each year for the last three years;
in the case of eradication programmes for IBR/IPV, by zone, if more than one zone is included in the territorial scope of the programme:
number of establishments keeping bovine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 at 31 December of each year for the last three years;
number of bovine animals kept in the establishments referred to in point (a) at 31 December of each year for the last three years;
number of establishments with the status free from IBR/IPV including establishments with suspended disease-free status at 31 December of each year for the last three years;
number of bovine animals kept in the establishments referred to in point (c) at 31 December of each year for the last three years;
number of establishments tested for IBR/IPV each year for the last three years;
number of establishments with suspicion following the testing referred to in point (e) each year for the last three years;
number of establishments confirmed infected with IBR/IPV each year for the last three years;
date of prohibition of vaccination against IBR/IPV of kept bovine animals;
in the case of eradication programmes for infection with ADV, by zone, if more than one zone is included in the territorial scope of the programme:
number of establishments keeping porcine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 at 31 December of each year for the last three years;
number of porcine animals kept in the establishments referred to in point (a) at 31 December of each year for the last three years;
number of establishments with the status free from infection with ADV including establishments with suspended disease-free status at 31 December of each year for the last three years;
number of porcine animals kept in the establishments referred to in point (c) at 31 December of each year for the last three years;
number of establishments where surveillance has been carried out to discover any clinical, virological or serological evidence of infection with ADV each year for the last three years;
number of porcine animals tested in the establishments referred to in point (e) each year for the last three years;
number of establishments confirmed infected with ADV each year for the last three years;
date of prohibition of vaccination against ADV of kept porcine animals;
in the case of eradication programmes for BVD, by zone, if more than one zone is included in the territorial scope of the programme:
number of establishments keeping bovine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 at 31 December of each year for the last three years;
number of bovine animals kept in the establishments referred to in point (a) at 31 December of each year for the last three years;
number of establishments with the status free from BVD including establishments with suspended disease-free status at 31 December of each year for the last three years;
number of bovine animals kept in the establishments referred to in point (c) at 31 December of each year for the last three years;
number of establishments tested for BVD each year for the last three years;
number of establishments with suspicion following the testing referred to in point (e) each year for the last three years;
number of establishments confirmed infected with BVD each year for the last three years;
date of prohibition of vaccination against BVD of kept bovine animals;
in case of eradication programmes for infection with RABV, by zone or region, if more than one region is included in the territorial scope of the programme, information on:
surveillance, including at least maps with data of:
indicator animals tested per species;
confirmed cases by species;
vaccination of wild animals:
number and dates of vaccination campaigns;
vaccine bait density achieved per zone or region and, if the total size of the vaccination area per vaccination campaign is greater than 20000 km2, vaccine bait density maps;
upon request of the Commission, electronic files with:
flight routes recorded during the vaccine bait distribution,
vaccine bait distribution: time and position of each bait released recorded during aerial distribution if the total size of the vaccination area per vaccination campaign is greater than 20000 km2;
monitoring of the effectiveness of the vaccination, with maps with data of:
number of animals positive to the biomarker test/number of biomarker tests performed,
number of animals positive to serological tests/number of serological tests;
number and results of the titration of the vaccine baits tests performed;
number of confirmed cases for which infection with RABV did not occur in the territory concerned (imported cases);
if epidemiological links in cases referred to in point (c) have been identified, the results of increased surveillance carried out over a period of 6 months following the death of the animal concerned, where relevant;
in case of eradication programmes for infection with BTV:
territorial scope with a map and a description and demarcation of the geographical and administrative areas covered by the eradication programme and the names of the zones and regions, if more than one region is included in the territorial scope of the programme; where relevant, the reasons for applying the derogation provided for in Article 37(3) of Delegated Regulation (EU) 2020/689 and evolution of the zone during the programme;
the number of establishments keeping animals of the targeted animal population on 31 December;
the number of animals of the targeted animal population kept in the establishments referred to in point (b) on 31 December;
sampling schemes implemented annually: mapping unit and selection criteria implemented, frequency of testing, number of tests, type of diagnostic methods and results;
number of confirmed cases by zone, species, year/months and BTV serotype(s);
number of animals vaccinated by year, species and BTV serotype(s);
derogations for movements granted, number of animals concerned and, where relevant, adaptation of the surveillance implemented;
coordinated measures with other Member States or third countries, where relevant, and adaptation of the surveillance to external sources of infection with BTV;
in the case of eradication programmes for category B and C diseases of aquatic animals, supply the following information for each year of the programme, by Member State, zone or compartment, as relevant to the territorial scope:
number of approved aquaculture establishments, and where relevant, the number of registered aquaculture establishments keeping animals of the targeted animal population and sampling points in wild populations, which are included in the eradication programme, as well as maps showing the location of establishments and sampling points in wild populations;
number of aquaculture establishments and, where relevant, sampling points in wild populations, out of the number of establishments and sampling points referred to in point (a), which are not infected;
number of animal health visits per approved and where relevant, registered aquaculture establishments;
number of samplings per approved and where relevant, registered aquaculture establishments and sampling points in wild populations, as well as details of species, results of sampling (positive or negative) and water temperatures at the time of sampling;
number of infected aquaculture establishments and, where relevant, sampling points in wild populations with confirmed cases(s) out of the number of establishments referred to in point (a);
number of new infected aquaculture establishments and, where relevant, sampling points in wild populations with confirmed case(s) out of the number of establishments referred to in point (a).